These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5271986)

  • 41. [Inhalation of cycloserine in the complex therapy of patients with pulmonary tuberculosis].
    Kulik NM
    Probl Tuberk; 1967; 45(5):38-40. PubMed ID: 5617943
    [No Abstract]   [Full Text] [Related]  

  • 42. [Comparative clinical electroencephalographic study of cycloserine and terizidon tolerance].
    Shmelev NA; Shabalova LN; Kolosovskaia VP
    Antibiotiki; 1975 Feb; 20(2):174-80. PubMed ID: 1091207
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cycloserine induced psychosis with hepatic dysfunction.
    Tandon VR; Rani N; Roshi ; Gupta R; Arora M; Khajuria V; Mahajan V
    Indian J Pharmacol; 2015; 47(2):230-1. PubMed ID: 25878391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cycloserine in hospital and then sanitarium environment (study of 12 cases)].
    Ollagnier C; Fourchon J; Perrin LF; Vallon C
    Rev Lyon Med; 1968 Jan; 17(1):39-43. PubMed ID: 5744478
    [No Abstract]   [Full Text] [Related]  

  • 45. [Depot drugs in the treatment of resistant forms of pulmonary tuberculosis. The experience of the Conjunto Sanatorial Octávio de Freitas (Recife)].
    Rizzo A; Moura N; Magalhães M; Antunes G; Campelo C
    Rev Bras Med; 1966 Dec; 23(12):850-2. PubMed ID: 5999012
    [No Abstract]   [Full Text] [Related]  

  • 46. Results of combined use of cycloserine in pulmonary tuberculosis.
    Tello F
    Scand J Respir Dis Suppl; 1970; 71():162-7. PubMed ID: 5271979
    [No Abstract]   [Full Text] [Related]  

  • 47. [Decomposition of INH and cycloserin preparations in the body of patients with tuberculosis of the lungs].
    Smirnov GA
    Probl Tuberk; 1977 Aug; (8):63-6. PubMed ID: 905277
    [No Abstract]   [Full Text] [Related]  

  • 48. [The influence of cycloserine on the metabolism of several B complex vitamins in pulmonary tuberculosis].
    Gol'dshteĭn VD; Fondaminskaia LD; Semenova AS
    Probl Tuberk; 1971; 49(11):15-9. PubMed ID: 5150983
    [No Abstract]   [Full Text] [Related]  

  • 49. [Collateral toxic effects of antitubercular drugs: acute psychopathies caused by cycloserine. (Case reports)].
    Zanotelli F; Ghidini O; Bertoni L
    G Clin Med; 1967 Sep; 48(9):972-84. PubMed ID: 5609866
    [No Abstract]   [Full Text] [Related]  

  • 50. [Cycloserine in treatment of children].
    Glowacka M; Kostrubala M
    Wiad Lek; 1966 Jun; 19(11):859-62. PubMed ID: 5296694
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of INH on the liver cell in patients with pulmonary tuberculosis and viral hepatitis.
    Kedrowa S; Krakówka P; Grymiński J
    Pol Med J; 1966; 5(2):345-9. PubMed ID: 5915721
    [No Abstract]   [Full Text] [Related]  

  • 52. [Comparative evaluation of several functional tests of the liver in patients with pulmonary tuberculosis with side-reactions to tuberculostatic preparations].
    Kaminskaia GO; Karachunskiĭ MA; Kolosovskaia VP
    Ter Arkh; 1969 Nov; 41(11):75-9. PubMed ID: 5384752
    [No Abstract]   [Full Text] [Related]  

  • 53. [Changes in the electroencephalogram and neuro-psychic disorders in patients with pulmonary tuberculosis during treatment with cycloserine].
    Chelnokova NV
    Antibiotiki; 1968 Oct; 13(10):918-25. PubMed ID: 5707364
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of cycloserine, ethionamide, and ethoxyd on liver function in pulmonary tuberculosis].
    Baĭl'dinova IM
    Ter Arkh; 1971 Jan; 43(1):101-4. PubMed ID: 5574526
    [No Abstract]   [Full Text] [Related]  

  • 55. [Combination of ethambutol with ethionamide, cycloserine and-or pyrazynamide in retreatment of pulmonary tuberculosis].
    Kekkaku; 1968 Feb; 43(2):91-5. PubMed ID: 5678013
    [No Abstract]   [Full Text] [Related]  

  • 56. [Ofloxacin-cycloserine-protionamide-INH combination against treatment refractory lung tuberculosis].
    Mühlberger F; Nturanye F; Nasbimana J; Portaels F
    Pneumologie; 1995 Feb; 49(2):72-6. PubMed ID: 7724506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A case of multi-drug resistant tuberculosis showing psychiatric adverse effect by cycloserine].
    Fujita J; Sunada K; Hayashi H; Hayashihara K; Saito T
    Kekkaku; 2008 Jan; 83(1):21-5. PubMed ID: 18283911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Inhibitory effect of D-cycloserine on beta-aminoisobutyric acid and beta-alanine metabolism. I. Increase of urinary excretion of beta-aminoisobutyric acid and beta-alanine of patients with pulmonary tuberculosis by administration of D-cycloserine, and elucidation of its mechanism].
    Yasumitsu T
    Kekkaku; 1973 May; 48(5):177-87. PubMed ID: 4732657
    [No Abstract]   [Full Text] [Related]  

  • 59. [Preliminary experiences with treatment of pulmonary tuberculosis with 1',4'-bis-D-(3-oxo-4-isoxazolidinyliminomethyl)-benzene (Terizidone)].
    Scarponi F; Dorigoni A
    Arch Maragliano Patol Clin; 1968; 24(4):457-70. PubMed ID: 5755799
    [No Abstract]   [Full Text] [Related]  

  • 60. [The problem of infectiousness of tuberculosis patients during chemotherapy].
    Schulthess HK; Zollikofer H
    Schweiz Med Wochenschr; 1981 Feb; 111(8):251-4. PubMed ID: 6785880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.